NCT07011550 2026-03-20Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal CancerM.D. Anderson Cancer CenterPhase 2 Suspended7 enrolled